Why the study?
Although dyslipidemia is linked to ICAS and ischemic stroke particularly in Asian populations, the specific role of familial hypercholesterolemia in stroke and ICAS risk in these populations remained unclear.
Does familial hypercholesterolemia increase the risk of intracranial major artery stenosis and symptomatic ischemic stroke in a Japanese population?
Does familial hypercholesterolemia increase the risk of intracranial major artery stenosis and symptomatic ischemic stroke in a Japanese population?
Familial hypercholesterolemia is associated with a substantially increased risk of intracranial major artery stenosis and symptomatic ischemic stroke in Japanese patients.
May warrant heightened vigilance for ICAS in FH; extends vascular risk to intracranial arteries in Japanese patients.[[1]](https://www.atherosclerosis-journal.
BACKGROUND AND AIMS The contribution of dyslipidemia to stroke risk is generally considered weaker than that of hypertension and diabetes. However, some previous studies suggest that dyslipidemia is associated with intracranial major artery stenosis (ICAS) and ischemic stroke, particularly in Asians populations, who are more susceptible to ICAS than Caucasians. We hypothesized that dyslipidemia, and specifically familial hypercholesterolemia (FH), may play a different role in the development of stroke in Asian populations. This study aimed to assess the prevalence and incidence of symptomatic ischemic stroke and ICAS in Japanese patients with FH compared to individuals undergoing Brain Dock. METHODS This prospective longitudinal study included FH patients who visited a lipid clinic and underwent brain magnetic resonance imaging (MRI) at the National Cerebral and Cardiovascular Center, alongside participants who underwent brain MRI as part of the Brain Dock screening program in Japan. RESULTS In total, 3178 participants who underwent Brain Dock and 150 patients with FH were included. FH was an independent risk factor of a higher prevalence of ICAS (≥50%; adjusted odds ratio: 17.82, 95% confidence interval [CI]: 8.74-36.36), and high symptomatic ischemic stroke incidence (adjusted hazard ratio [aHR]: 5.83, 95% CI: 2.03-16.77). The presence of ICAS was significantly associated with symptomatic ischemic stroke in patients with FH (aHR: 7.73, 95% CI: 1.53-39.06). CONCLUSIONS FH may confer a high risk for symptomatic ischemic stroke along with intracranial major artery changes in Japanese patients. These findings highlight the importance of considering ethnic and genetic differences in stroke prevention strategies.
No takes yet. Share an insight, caveat, or question.
Hattori et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: